Phyllanthus emblica and Withania somnifera compositions for endothelial function
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for endothelial dysfunction and diabetes mellitus are inadequate in effectively addressing oxidative stress and cardiovascular health, with existing therapies often having adverse effects and limited efficacy.
Innovation Solution
Development of compositions comprising Phyllanthus emblica and Withania somnifera extracts, which are administered to improve endothelial function and cardiovascular health by reducing oxidative stress and inflammation, and enhancing nitric oxide bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard treatments are used for endothelial dysfunction and diabetes, then cardiovascular health is addressed, but adverse effects occur and efficacy is limited
Solution Approach 1:
The patent employs natural plant extracts (Phyllanthus emblica and Withania somnifera) as temporary, renewable therapeutic agents that can be administered repeatedly without accumulating toxic effects, replacing long-term conventional medications that cause adverse effects
Solution Approach 2:
The invention combines two different plant extracts with complementary mechanisms of action - Phyllanthus emblica for antioxidant activity and Withania somnifera for adaptogenic and cardioprotective effects - creating a composite formulation that addresses multiple aspects of endothelial dysfunction and diabetes simultaneously
2Reliability
If oxidative stress is reduced to improve endothelial function, then cardiovascular health improves, but current therapies are inadequate
Solution Approach 1:
The plant extract composition performs multiple therapeutic functions simultaneously: antioxidant activity to reduce oxidative stress, anti-inflammatory effects to decrease vascular inflammation, nitric oxide bioavailability enhancement to improve vasodilation, and cardioprotective effects - making it a versatile treatment for endothelial dysfunction and diabetes
Solution Approach 2:
The invention changes the chemical and biological parameters of the therapeutic intervention by using natural plant compounds with broad-spectrum bioactive properties, altering the mechanism of action from targeted molecular inhibition to multifaceted physiological modulation that addresses oxidative stress and endothelial dysfunction more effectively
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of Phyllanthus emblica and Withania somnifera compositions significantly improves endothelial function, reduces markers of oxidative stress, and enhances cardiovascular parameters in patients with type 2 diabetes mellitus, comparable to standard treatments like atorvastatin.
Implementation Method 1
PE demonstrates potent antioxidant effects against several test systems such as superoxide radical and hydroxyl radical scavenging action
Implementation Method 2
The endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO) mainly due to accelerated NO degradation by reactive oxygen species
Implementation Method 3
Many herbs possess potent antioxidant, anti-inflammatory and cardio-protective properties
Data Source
AI summary
Compositions of natural antioxidants, especially those derived from Phyllanthus emblica and Withania somnifera, and combinations thereof, are provided. The compositions may be used for improvement of endothelial function and cardiovascular health, including treatment of diabetes.